Ampreloxetine clinical trials

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

This study is testing a new medicine, Ampreloxetine, for people with Multiple System Atrophy (MSA) who experience dizzy spells upon standing. It will check how well the medicine works and for how long, compared to a dummy pill, over about 20 weeks.